Relief Therapeutics (OTCMKTS:RLFTF) Shares Down 1% – Here’s What Happened

Relief Therapeutics Holding SA (OTCMKTS:RLFTF)’s share price traded down 1% on Friday . The company traded as low as $0.3799 and last traded at $0.3799. 2,429 shares traded hands during trading, a decline of 11% from the average session volume of 2,722 shares. The stock had previously closed at $0.3836.

Relief Therapeutics Trading Down 1.0%

The stock’s fifty day moving average price is $0.87 and its two-hundred day moving average price is $2.34.

Relief Therapeutics Company Profile

Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.

The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.